Regio- and Enantioselective Alkene Difunctionalizations for the Synthesis of Bioactive Molecules.
Regio- and Enantioselective Alkene Difunctionalizations for the Synthesis of Bioactive Molecules.
批准号:
10046958
负责人:
Wei Li
金额:
$45.15万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-09-01 至 2023-08-31
关键词:
AdoptedAlkenesAmidesAmino AlcoholsBenchmarkingCarbamatesCatalysisChemicalsCollectionCouplingCross-Linking ReagentsDataDevelopmentElementsGoalsIodineLigandsMethodsNitrilesNitrogenOrganic SynthesisOsmiumPharmaceutical PreparationsPharmacologic SubstanceProtocols documentationReactionSolidStructureUreabasecatalystchemical reactioncycloadditiondesigndrug candidatedrug discoverydrug productioninnovationinventionnovelprogramspublic health relevance
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
Chiral β-amino functionalized molecules are common motifs often found in a variety of saturated heterocycles
of important drug molecules. They are also ubiquitous chiral building blocks in organic synthesis to access, for
example, chiral oxazoline-based ligands that are broadly useful in asymmetric catalysis. The functional
importance of these molecules renders their syntheses continuously in high demand. Alkene difunctionalization
represents a highly modular strategy towards these structural motifs as benchmarked by the venerable
osmium-catalyzed protocols developed by Sharpless and coworkers. However, significant challenges remain
for this class of reactions. The main objective of this program is to develop new classes of catalytic alkene
difunctionalizations that will meet the demands of these challenges and expedite access to chiral β-amino
functionalized motifs. Specifically, this proposal will introduce halonium and hypervalent iodine catalysis as
platforms to resolve the regiochemical and enantioselective challenges often encountered in these reactions.
Based on solid preliminary data, the proposed studies will enable us to: 1) demonstrate the feasibility of
nucleophile-control for regiochemical control in halonium catalysis with a range of bifunctional nucleophiles; 2)
utilize hypervalent iodine catalysts as a new element for regiocontrol in alkene difunctionalizations; and 3)
adopt chiral hypervalent iodine catalyst for asymmetric induction of the reactions proposed. Our proposal is
innovative by introducing several means of regiocontrol and asymmetric induction based on a single
elementary step. Additionally, these methods use simple and ubiquitous bifunctional reagents such as amide,
urea, carbamate, etc. for alkene difunctionalizations. Finally, realization of the proposed strategy will enable
straightforward synthesis of chiral β-amino functionalized motifs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Developing a novel disease-targeted anti-angiogenic therapy for CNV
-
批准号:10726508
-
项目类别:
-
资助金额:$44.0万
-
财政年份:2023
-
负责人:Wei Li
-
依托单位:
Integrative genomic and functional genomic studies to connect variant to function for CAD GWAS loci
-
批准号:10639274
-
项目类别:
-
资助金额:$80.25万
-
财政年份:2023
-
负责人:Wei Li
-
依托单位:
IMAT-ITCR Collaboration: Develop deep learning-based methods to identify subtypes of circulating tumor cells from optical microscope images
-
批准号:10675886
-
项目类别:
-
资助金额:$7.19万
-
财政年份:2022
-
负责人:Wei Li
-
依托单位:
The Pathophysiological Role of Cerebellar Glia in Rett Syndrome
-
批准号:10183494
-
项目类别:
-
资助金额:$39.94万
-
财政年份:2021
-
负责人:Wei Li
-
依托单位:
The role and mechanism of necrosis in glioblastoma
-
批准号:10097263
-
项目类别:
-
资助金额:$39.35万
-
财政年份:2021
-
负责人:Wei Li
-
依托单位:
The role and mechanism of necrosis in glioblastoma
-
批准号:10330992
-
项目类别:
-
资助金额:$39.35万
-
财政年份:2021
-
负责人:Wei Li
-
依托单位:
The Pathophysiological Role of Cerebellar Glia in Rett Syndrome
-
批准号:10591567
-
项目类别:
-
资助金额:$36.49万
-
财政年份:2021
-
负责人:Wei Li
-
依托单位:
The role and mechanism of necrosis in glioblastoma
-
批准号:10553723
-
项目类别:
-
资助金额:$39.35万
-
财政年份:2021
-
负责人:Wei Li
-
依托单位:
The Pathophysiological Role of Cerebellar Glia in Rett Syndrome
-
批准号:10380144
-
项目类别:
-
资助金额:$36.49万
-
财政年份:2021
-
负责人:Wei Li
-
依托单位:
A new drug entity for combination therapy of diabetic retinopathy
-
批准号:10255782
-
项目类别:
-
资助金额:$25.66万
-
财政年份:2021
-
负责人:Wei Li
-
依托单位:
Transfer: DNA Methylation Canyons in Human Cancers: Methods, Target Genes and Functional Consequences
-
批准号:10119943
-
项目类别:
-
资助金额:$57.42万
-
财政年份:2020
-
负责人:Wei Li
-
依托单位:
Transfer: DNA Methylation Canyons in Human Cancers: Methods, Target Genes and Functional Consequences
-
批准号:10543784
-
项目类别:
-
资助金额:$55.02万
-
财政年份:2020
-
负责人:Wei Li
-
依托单位:
Transfer: DNA Methylation Canyons in Human Cancers: Methods, Target Genes and Functional Consequences
-
批准号:10330018
-
项目类别:
-
资助金额:$55.02万
-
财政年份:2020
-
负责人:Wei Li
-
依托单位:
Anti-angiogenic gene therapy of ocular vascular diseases
-
批准号:9909566
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2020
-
负责人:Wei Li
-
依托单位:
Computational and Experimental Modeling of Epigenetic DNA Methylation
-
批准号:10091784
-
项目类别:
-
资助金额:$36.77万
-
财政年份:2020
-
负责人:Wei Li
-
依托单位:
Impaired Astroglial Glutamate Signaling in Rett Syndrome
-
批准号:10116102
-
项目类别:
-
资助金额:$40.84万
-
财政年份:2020
-
负责人:Wei Li
-
依托单位:
Fractionation and Profiling of Heterogeneous Circulating Tumor Cells Using a Hyperuniform- Structured Microchip
-
批准号:10025872
-
项目类别:
-
资助金额:$55.31万
-
财政年份:2020
-
负责人:Wei Li
-
依托单位:
Thymidine Phosphorylase: a Novel Target of Antiplatelet Therapy
-
批准号:10448031
-
项目类别:
-
资助金额:$44.4万
-
财政年份:2019
-
负责人:Wei Li
-
依托单位:
A selective angiogenesis blocker to treat retinopathy of prematurity
-
批准号:10580497
-
项目类别:
-
资助金额:$7.6万
-
财政年份:2019
-
负责人:Wei Li
-
依托单位:
Modeling Functional Elements using CRISPR Screening
-
批准号:10627916
-
项目类别:
-
资助金额:$44.63万
-
财政年份:2019
-
负责人:Wei Li
-
依托单位:
海外基金